These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 34727923)

  • 21. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inverse correlation between average monthly high temperatures and COVID-19-related death rates in different geographical areas.
    Benedetti F; Pachetti M; Marini B; Ippodrino R; Gallo RC; Ciccozzi M; Zella D
    J Transl Med; 2020 Jun; 18(1):251. PubMed ID: 32576227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The theoretical mortality risk of an asymptomatic patient with a negative SARS-CoV-2 test developing COVID-19 following elective orthopaedic surgery.
    Kader N; Clement ND; Patel VR; Caplan N; Banaszkiewicz P; Kader D
    Bone Joint J; 2020 Sep; 102-B(9):1256-1260. PubMed ID: 32627569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study.
    Ioannou GN; Ferguson JM; O'Hare AM; Bohnert ASB; Backus LI; Boyko EJ; Osborne TF; Maciejewski ML; Bowling CB; Hynes DM; Iwashyna TJ; Saysana M; Green P; Berry K
    PLoS Med; 2021 Oct; 18(10):e1003807. PubMed ID: 34673772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-endoscopy SARS-CoV-2 testing strategy during COVID-19 pandemic: the care must go on.
    Casper M; Reichert MC; Rissland J; Smola S; Lammert F; Krawczyk M
    Eur J Med Res; 2022 Mar; 27(1):41. PubMed ID: 35303954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation.
    Rubino S; Kelvin N; Bermejo-Martin JF; Kelvin D
    J Infect Dev Ctries; 2020 Mar; 14(3):265-267. PubMed ID: 32235086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An assessment of case-fatality and infection-fatality rates of first and second COVID-19 waves in Italy.
    Filippini T; Zagnoli F; Bosi M; Giannone ME; Marchesi C; Vinceti M
    Acta Biomed; 2021 Oct; 92(S6):e2021420. PubMed ID: 34739462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of SARS-CoV-2 RT-PCR test results from a pandemic hospital according to demographic data.
    Dinc B; Kirca F; Aydogan S; Toyran A; Basyigit T; Omay I; Gun P; Caglayan M; Surel AA
    Public Health; 2021 Sep; 198():208-210. PubMed ID: 34481276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wastewater monitoring of SARS-CoV-2 shows high correlation with COVID-19 case numbers and allowed early detection of the first confirmed B.1.1.529 infection in Switzerland: results of an observational surveillance study.
    Bagutti C; Alt Hug M; Heim P; Maurer Pekerman L; Ilg Hampe E; Hübner P; Fuchs S; Savic M; Stadler T; Topolsky I; Icer Baykal P; Dreifuss D; Beerenwinkel N; Tschudin Sutter S
    Swiss Med Wkly; 2022 Jun; 152():w30202. PubMed ID: 35822578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Checkpoint Travel Numbers as a Proxy Variable in Population-Based Studies During the COVID-19 Pandemic: Validation Study.
    Kreslake JM; Aarvig K; Muller-Tabanera H; Vallone DM; Hair EC
    JMIR Public Health Surveill; 2023 Aug; 9():e44950. PubMed ID: 37191643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using hierarchical clustering analysis to evaluate COVID-19 pandemic preparedness and performance in 180 countries in 2020.
    Sadeghi B; Cheung RCY; Hanbury M
    BMJ Open; 2021 Nov; 11(11):e049844. PubMed ID: 34753756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the epidemiological profile of SARS-CoV-2-positive individuals in Mexico across pandemic waves as an explanation of fatality reduction: a retrospective observational study.
    Gutierrez JP; López D; Ascencio I; Juárez A; Olaiz G; Bertozzi SM
    BMJ Open; 2023 May; 13(5):e063211. PubMed ID: 37221025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of SARS-CoV-2 in urban settings in three sub-Saharan African countries (SeroCoV): a study protocol for a household-based cross-sectional prevalence study using two-stage cluster sampling.
    Lorenz E; Souares A; Amuasi J; Loag W; Deschermeier C; Fusco D; Benke D; A Rakotoarivelo R; Rasamoelina MT; Rakotozandrindrainy R; Sie A; Afum-Adjei Awuah A; May J; Eibach D; Struck N
    BMJ Open; 2021 Dec; 11(12):e056853. PubMed ID: 34921091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analyzing COVID-19 pandemic for unequal distribution of tests, identified cases, deaths, and fatality rates in the top 18 countries.
    Shams SA; Haleem A; Javaid M
    Diabetes Metab Syndr; 2020; 14(5):953-961. PubMed ID: 32604014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Was Alpha deadlier than wild-type COVID? Analysis in rural England.
    Brainard J; Grossi Sampedro CM; Sweeting A; Fordham R
    Infection; 2022 Oct; 50(5):1171-1178. PubMed ID: 35247164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Infection fatality rate (IFR) during the course of COVID-19 pandemic in Upper Silesia Metropolitan Area (Poland) in 2020].
    Zejda JE; Kowalska M; Brożek GM; Barański K; Kaleta-Pilarska A
    Med Pr; 2021 Dec; 72(6):671-676. PubMed ID: 34751682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seropositivity rate and diagnostic accuracy of serological tests in 2019-nCoV cases: a pooled analysis of individual studies.
    Guo CC; Mi JQ; Nie H
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10208-10218. PubMed ID: 33090430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.